Ruben Niesvizky, M.D.
As the Director of the Multiple Myeloma Service at the Center of Excellence for Lymphoma and Myeloma at New York Presbyterian Hospital-Cornell Medical Center, my duties will focus on providing outstanding clinical care and coordinating a world class clinical translational research program. Prestigious investigators have joined forces to create one of the leading centers for myeloma research. I have no doubt that this cooperative effort forms one of the best myeloma research groups on the World.
My 20 years of experience as a myeloma physician has helped me to appreciate how important it is to treat patients in the context of a comprehensive program. New York Presbyterian Hospital has an outstanding Bone Marrow Transplant Service (a treatment modality often used for myeloma patients), performing more than 100 transplants per year. It has also been rated the best in the world in the fields of cardiology (heart), neurosurgery and nephrology (kidney). The Hospital for Special Surgery, also part of the New York Presbyterian-Weill Cornell system, has an outstanding group of orthopedic surgeons that support a new comprehensive bone disease program. In addition, as part of our continuing search for more effective therapeutic options, we offer multiple clinical trials utilizing promising new drugs and medical procedures for treating myeloma and related hematological disorders.
The ultimate goal is to find the cure for multiple myeloma. The establishment of a strong Multiple Myeloma Center of Excellence at New York Presbyterian Hospital Weill Cornell Medical Center is an important step towards the accomplishment of this goal.
For more information, please click here: http://www.Myelomacenter.org
Dr. Niesvizky is Associate Professor of Medicine at Weill Medical College of Cornell University and at NewYork Presbyterian Hospital/Weill Cornell Medical Center in Manhattan. He also serves as Director of the Multiple Myeloma Service at the Center of Excellence for Lymphoma and Myeloma at NewYork Presbyterian Hospital/Weill Cornell Medical Center. After receiving a medical degree from National University of Mexico, Dr. Niesvizky did a research fellowship in cell biology-granulomonopoiesis and an internal medicine residency at the National Institute of Nutrition in Mexico. He then completed fellowships in New York: one (hematology) at Mount Sinai Medical Center and one (hematology/medical oncology) at Memorial Sloan-Kettering Cancer Center. He has written more than 50 articles, editorials, chapters, and abstracts published in journals such as New England Journal of Medicine, Blood and Leukemia & Lymphoma, most recently on topics such as the treatment of myeloma and Waldenstrom's macroglobulinemia. He is the recipient of various grants and awards from the National Cancer Institute, including a K23 award and two translational research grants. He recently received the 2007 Investigator Award of the Michael Wolk Heart Foundation. A frequent lecturer, Dr Niesvizky regularly presents at annual meetings of the American Society of Hematology and the American Society of Clinical Oncology, of which he is also a member. He is an active participant in clinical trials of promising new drugs and medical procedures for the treatment of myeloma, lymphoma, and related hematologic disorders.